Press Release Archive

2021  2020  2019  2018   2017
2016  2015
2014   2013
2012   2011 2010   2009
2008   2007


Stuttgart, January 2021 – The Thieme Group has concluded a transformation agreement with ZB MED – Information Centre for Life Sciences, the Forschungszentrum Jülich and eight other specialist libraries. As part of the current agreement, which comes into effect on 1 January 2021, authors of the participating institutions receive the opportunity to publish original papers in four international specialist Thieme journals on an open access basis without additional costs. The offer includes the publications International Journal of Sports Medicine, Pharmacopsychiatry, Thrombosis and Haemostasis and Methods of Information in Medicine. Thieme already reached a similar agreement in 2019. The pilot project was initially restricted to the specialist journal Hormone and Metabolic Research.

The Thieme Group’s new agreement with the ten members of the expandable library consortium regulates the step-by-step transformation of an existing subscription model into open access funding. “We are vigorously working on the transformation of the previous business model. The important thing is to create transparent and fair conditions for all participants,” explains Thieme publisher Dr h.c. Albrecht Hauff. “The transformation agreement reached in 2019 has shown how important it is to conclude forward-looking agreements that go beyond large projects such as DEAL.”

For the use of the selected Thieme specialist journals in the new business model, in the coming five years the participating specialist libraries will pay a fee consisting of a licence for reading and a publication lump sum for the open access publication of authors at these institutions. Here, the number of open access publications is not limited. The specialist journals in question were consciously chosen by the participants: each publication covers a very research-intensive domain in which German scientists publish extensively. After approximately half of the agreement term, the contractual partners will review jointly how the open access submissions are developing. In the process, the licence fee will be gradually converted into a publication fee.

“ZB MED promotes open and reproducible science in the interests of open science and FAIR principles. Therefore, we have been committed to open access for many years,” emphasises managing director Gabriele Herrmann-Krotz. “In the Thieme Group, the libraries have found a reliable partner, and we are pleased that we are now able to expand further the good collaboration after the pilot project two years ago,” Herrmann-Krotz continues.

Dr Bernhard Mittermaier, head of the central library of the Forschungszentrum Jülich and a participant in the DEAL negotiations, stresses the significance of the agreement in terms of scientific policy: “With the agreements now reached, we are taking a further important step – complementing the DEAL negotiations with the world’s three largest publishers – in continuously advancing the conversion into open access, including at small and medium-sized publishers.” The progress of the transformation is being documented in the Open Access Monitor Deutschland, run by the Forschungszentrum Jülich.

The quality assurance of the publications is a crucial aspect for all participating project partners. The services of the Thieme Group are just as extensive in open-access publications as in traditional magazine articles. The Group gladly offers a high-standard peer review by internationally leading experts as well as professional editing for open access articles.

“It is pleasing that, for the first time, we have agreed a transformation contract for a package of publications with which we and our participants can gain further valuable experience with open access,” explains Maja Laisse, Director Sales Institutional Sales at Thieme. About the Forschungszentrum Jülich

Conducting research for a changing society: This is the mission of more than 6,000 employees working hand in hand at Forschungszentrum Jülich, including 600 visiting scientists from 59 countries. Their common objective: research that has an impact. That is why experts at Forschungszentrum Jülich are researching fundamentals, technologies, and systems of a digitized society, a climate-friendly energy system, and a resource-efficient economy. At Jülich, natural, life and engineering sciences in the fields of information, energy, and the bioeconomy are closely linked here with special expertise in high-performance computing and benefit from the use of unique scientific infrastructure. Forschungszentrum Jülich is one of the largest interdisciplinary research institutions in Europe and contribute to solving the grand societal challenges of our time as a member of the Helmholtz Association.

About Thieme
Thieme is a leading supplier of information and services contributing to the improvement of healthcare and health. Employing more than 1,000 staff, the family-owned company develops products and services in digital and other media for the medical and chemistry sectors. Operating internationally with offices in 11 cities worldwide, the Thieme Group works closely with a strong network of experts and partners. The products and services are based on the high-quality content of Thieme’s and 4,400 books 200 medical and scientific journals. These include more than 50 dedicated open access journals as well as numerous hybrid publications. This is all based on comprehensive services and many years of experience in communicating scientific information. With solutions for professionals, Thieme supports information processes in research, education, and patient care. Medical students, physicians, nurses, allied health specialists, hospitals, health insurance companies and others interested in health and healthcare are at focus of Thieme’s activities. The mission of the Thieme Group is to provide these markets with precisely the information, services, and products they need in their specific work situation and career. Providing top-quality services that are highly relevant to specific audiences, Thieme contributes to better healthcare and healthier lives. For more information about Thieme, please visit

About ZB MED – Information Centre for Life Sciences
ZB MED – Information Centre for Life Sciences is an infrastructure and research centre for information and data in the life sciences. Its goal is to support and strengthen research for the benefit of people and the environment: from medicine and biodiversity to environmental protection. As a central information hub for the life sciences, ZB MED offers a combination of nationwide access to information, big data analyses and knowledge transfer. By providing researchers with extensive support for open science practices along the entire research cycle, it paves the way for new insights that generate information and knowledge for the life sciences.

Press contact: Forschungszentrum Jülich
Annette Stettien
Corporate Communications
Forschungszentrum Jülich
Phone: +49 2461 61-2388
This email address is being protected from spambots. You need JavaScript enabled to view it.

Press contact: Thieme Group
Anne-Katrin Döbler
Thieme Communications
Thieme Group
Ruedigerstraße 14, 70469 Stuttgart, Germany
Phone: +49 711 8931-115
Fax: +49 711 8931-167
This email address is being protected from spambots. You need JavaScript enabled to view it.
Domicile and Commercial Register: Stuttgart, HRA 3499

Press contact: ZB MED
Ulrike Ostrzinski
ZB MED Press Officer
Phone +49 221 478-5687
This email address is being protected from spambots. You need JavaScript enabled to view it.


Sign up and be the first to get exclusive offers, sales, events, and more!

Yes, I would like to receive email newsletters with the latest news and information on products and services from Thieme Medical Publishers, Inc and selected cooperation partners in medicine and science regularly (about once a week). I agree to the use and processing of my personal information for this purpose. I can opt out at any time by clicking the "unsubscribe" link at the end of each newsletter.

Further information about data processing and your corresponding rights.

*Required field; all other fields are voluntary. We only use this information to personally address you in your newsletter.